Originally published by our sister publication Gastroenterology & Endoscopy News
Managed care leaders like to keep an eye on methods for detecting cancer and intervening early to maximize clinical outcomes. In the case of hepatocellular carcinoma (HCC), a new survey-based study suggests that numerous obstacles exist on both the provider and system levels when it comes to achieving that goal via optimal surveillance.
“Most cases of HCC occur in patients with known risk factors, and